Inventor
MATERN HUGO
US21 patents
Patents
21 patentsUS9920118B2Mar 20, 2018
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC19 citations94
US9161966B2Oct 20, 2015
GDF15 mutein polypeptides
NGM BIOPHARMACEUTICALS INC29 citations93
US9827291B2Nov 28, 2017
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC16 citations92
US9828415B2Nov 28, 2017
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC17 citations90
US10562965B2Feb 18, 2020
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC5 citations84
US10174119B2Jan 8, 2019
Binding proteins and methods of use thereof
NGM BIOPHARMACEUTICALS INC10 citations84
US10610568B2Apr 7, 2020
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC5 citations83
US10093735B2Oct 9, 2018
Beta-klotho binding proteins
NGM BIOPHARMACEUTICALS INC4 citations83
US9738716B2Aug 22, 2017
Beta klotho binding proteins and methods of use thereof
NGM BIOPHARMACEUTICALS INC9 citations83
US10323075B2Jun 18, 2019
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC8 citations82
US11530260B2Dec 20, 2022
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC2 citations73
US10975154B2Apr 13, 2021
Binding proteins and methods of use thereof
NGM BIOPHARMACEUTICALS INC2 citations73
US11596676B2Mar 7, 2023
Methods of treating nonalcoholic steatohepatitis comprising administering an anti-human beta klotho antibody or binding fragment thereof
NGM BIOPHARMACEUTICALS INC1 citations72
US10995145B2May 4, 2021
Antibodies which bind human glucagon receptor
NGM BIOPHARMACEUTICALS INC2 citations72
US10800843B2Oct 13, 2020
Beta klotho-binding proteins
NGM BIOPHARMACEUTICALS INC3 citations72
US10744191B2Aug 18, 2020
Beta klotho-binding proteins and methods of use thereof
NGM BIOPHARMACEUTICALS INC3 citations72
US12378312B2Aug 5, 2025
Polynucleotides encoding human beta klotho antibodies or binding fragments thereof and methods of use thereof
NGM BIOPHARMACEUTICALS INC0 citations62
US12180289B2Dec 31, 2024
Binding proteins and methods of use thereof
NGM BIOPHARMACEUTICALS INC0 citations62
US12173060B2Dec 24, 2024
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC0 citations62
US11732049B2Aug 22, 2023
Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor
NGM BIOPHARMACEUTICALS INC0 citations62
US11667708B2Jun 6, 2023
Anti-human beta klotho antibody or binding fragment thereof and methods of their use
NGM BIOPHARMACEUTICALS INC1 citations62